Income Statement Takara Holdings Inc.

Equities

2531

JP3459600007

Distillers & Wineries

Delayed Japan Exchange Other stock markets 12:00:00 12/05/2026 pm IST			5-day change	1st Jan Change
1,810.50 ^JPY	-0.47%		-1.20%	+12.66%

07/04	Takara Holdings Tender Offer Lifts Stake in Takara Bio to 87%	MT
06/04	Takara Holdings Inc. completed the acquisition of remaining 26.35% stake in Takara Bio Inc. from group of shareholders for ¥36.4 billion.	CI

f0c36661f2f205af4324905.9juvfBmmPUEfxCsitrRZ6O8WE017OzgbZpSuDec4N30.n23cS0nwdRIroR9yheIgnNluciIKVmpYDf_LPKhLACyXaccsSfdxD3jpXA

Published financial data: TAKARA HOLDINGS INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	28TCr	30TCr	35TCr	34TCr	36TCr
Total Revenues	28TCr	30TCr	35TCr	34TCr	36TCr
Cost of Goods Sold, Total	16TCr	19TCr	23TCr	23TCr	24TCr
Gross Profit	12TCr	11TCr	12TCr	11TCr	12TCr
Selling General & Admin Expenses, Total	8.37TCr	6.12TCr	7.01TCr	7.94TCr	8.74TCr
R&D Expenses	591.4Cr	648.4Cr	894.9Cr	872.5Cr	730.9Cr
Depreciation & Amortization - (IS)	231.3Cr	254.2Cr	292.2Cr	354.5Cr	431.4Cr
Other Operating Expenses	204.9Cr	-	-	-	-
Other Operating Expenses, Total	9.4TCr	7.02TCr	8.2TCr	9.17TCr	9.9TCr
Operating Income	2.16TCr	4.34TCr	3.79TCr	2.22TCr	2.06TCr
Interest Expense, Total	-34Cr	-33Cr	-32Cr	-45Cr	-70Cr
Interest And Investment Income	71Cr	77Cr	106.5Cr	140.5Cr	192.7Cr
Net Interest Expenses	36Cr	44Cr	74Cr	96Cr	122.7Cr
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-	-81Cr	-22Cr	-	-
Other Non Operating Income (Expenses)	9.7Cr	25Cr	24Cr	14Cr	35Cr
EBT, Excl. Unusual Items	2.21TCr	4.32TCr	3.87TCr	2.33TCr	2.22TCr
Gain (Loss) On Sale Of Investments	20L	-	67Cr	397.1Cr	369.6Cr
Gain (Loss) On Sale Of Assets	-42Cr	-	-24Cr	-84Cr	29Cr
Asset Writedown	-95Cr	-447Cr	-	-21Cr	-38Cr
Other Unusual Items	-10Cr	220Cr	55Cr	-2Cr	2.9Cr
EBT, Incl. Unusual Items	2.06TCr	4.1TCr	3.97TCr	2.62TCr	2.58TCr
Income Tax Expense	632.6Cr	1.16TCr	1.1TCr	847.2Cr	849.2Cr
Earnings From Continuing Operations	1.43TCr	2.94TCr	2.87TCr	1.78TCr	1.73TCr
Net Income to Company	1.43TCr	2.94TCr	2.87TCr	1.78TCr	1.73TCr
Minority Interest	-368.2Cr	-860.1Cr	-748.3Cr	-158.9Cr	-112Cr
Net Income - (IS)	1.06TCr	2.08TCr	2.12TCr	1.62TCr	1.62TCr
Net Income to Common Incl Extra Items	1.06TCr	2.08TCr	2.12TCr	1.62TCr	1.62TCr
Net Income to Common Excl. Extra Items	1.06TCr	2.08TCr	2.12TCr	1.62TCr	1.62TCr
Per Share Items
Net EPS - Basic	53.48	105.05	107.26	82.09	82.98
Basic EPS - Continuing Operations	53.48	105.05	107.26	82.09	82.98
Basic Weighted Average Shares Outstanding	20Cr	20Cr	20Cr	20Cr	20Cr
Net EPS - Diluted	53.48	105.05	107.26	82.09	82.98
Diluted EPS - Continuing Operations	53.48	105.05	107.26	82.09	82.98
Diluted Weighted Average Shares Outstanding	20Cr	20Cr	20Cr	20Cr	20Cr
Normalized Basic EPS	51.1	93.16	84.5	65.95	65.26
Normalized Diluted EPS	51.1	93.16	84.5	65.95	65.26
Dividend Per Share	21	37	38	29	31
Payout Ratio	37.37	19.97	34.45	46.38	34.93
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	3.05TCr	5.27TCr	4.81TCr	3.34TCr	3.27TCr
EBITA	2.25TCr	4.42TCr	3.89TCr	2.34TCr	2.23TCr
EBIT	2.16TCr	4.34TCr	3.79TCr	2.22TCr	2.06TCr
Effective Tax Rate - (Ratio)	30.74	28.3	27.72	32.29	32.9
Normalized Net Income	1.01TCr	1.84TCr	1.67TCr	1.3TCr	1.27TCr
Non-Cash Pension Expense	-60L	27Cr	22Cr	26Cr	26Cr
Supplemental Operating Expense Items
Advertising Expense	3.43TCr	639.3Cr	706Cr	914.4Cr	814.6Cr
Selling and Marketing Expenses	4.32TCr	1.64TCr	1.82TCr	2.05TCr	2.03TCr
Research And Development Expense From Footnotes	591.4Cr	648.4Cr	894.9Cr	872.5Cr	730.9Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	6.62TCr	8.04TCr	9.68TCr	9.51TCr	8.33TCr
Short Term Investments	114.5Cr	117.9Cr	-	-	-
Total Cash And Short Term Investments	6.74TCr	8.16TCr	9.68TCr	9.51TCr	8.33TCr
Accounts Receivable, Total	6.14TCr	6.98TCr	6.9TCr	6.93TCr	7.26TCr
Total Receivables	6.14TCr	6.98TCr	6.9TCr	6.93TCr	7.26TCr
Inventory	4.91TCr	7.26TCr	6.69TCr	7.11TCr	8.23TCr
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	516.4Cr	824.7Cr	876.8Cr	977.2Cr	721.9Cr
Total Current Assets	18TCr	23TCr	24TCr	25TCr	25TCr
Net Property Plant And Equipment	7.47TCr	7.97TCr	8.89TCr	10TCr	12TCr
Long-term Investments	3.11TCr	3.23TCr	5.07TCr	6.71TCr	6.47TCr
Goodwill	1.01TCr	1.01TCr	1.07TCr	1.22TCr	2.53TCr
Other Intangibles, Total	574.7Cr	529Cr	526.3Cr	618.2Cr	1.64TCr
Deferred Tax Assets Long-Term	208.8Cr	268.2Cr	217Cr	191.3Cr	213.2Cr
Other Long-Term Assets, Total	10L	20L	20L	10L	20L
Total Assets	31TCr	36TCr	40TCr	44TCr	48TCr
Liabilities
Accounts Payable, Total	1.65TCr	2.1TCr	2.18TCr	2.23TCr	2.41TCr
Accrued Expenses, Total	918.2Cr	874Cr	974.8Cr	1.23TCr	343.8Cr
Short-term Borrowings	516.6Cr	549.7Cr	491.9Cr	1TCr	1.23TCr
Current Portion of Long-Term Debt	-	1TCr	-	500Cr	-
Current Income Taxes Payable	1.09TCr	1.38TCr	803.5Cr	1.08TCr	274.2Cr
Other Current Liabilities	1.45TCr	2.02TCr	2.3TCr	2.03TCr	3.09TCr
Total Current Liabilities	5.63TCr	7.92TCr	6.75TCr	8.07TCr	7.34TCr
Long-Term Debt	3.55TCr	3.52TCr	3.52TCr	2.54TCr	4.57TCr
Long-Term Leases	312.2Cr	300.5Cr	445.2Cr	736.9Cr	759.6Cr
Pension & Other Post Retirement Benefits	927.4Cr	894.4Cr	892.5Cr	873.5Cr	834.5Cr
Deferred Tax Liability Non Current	383.1Cr	396.9Cr	485.5Cr	880.6Cr	927.6Cr
Other Non Current Liabilities	742.4Cr	756.7Cr	2.3TCr	2.6TCr	3.24TCr
Total Liabilities	12TCr	14TCr	14TCr	16TCr	18TCr
Common Stock, Total	1.32TCr	1.32TCr	1.32TCr	1.32TCr	1.32TCr
Additional Paid In Capital	229.2Cr	249.9Cr	199.4Cr	271.6Cr	280.4Cr
Retained Earnings	14TCr	15TCr	16TCr	17TCr	18TCr
Treasury Stock	-168.2Cr	-168.2Cr	-168.2Cr	-210.3Cr	-210.3Cr
Comprehensive Income and Other	786.3Cr	1.64TCr	2.66TCr	4.49TCr	5.09TCr
Total Common Equity	16TCr	18TCr	20TCr	23TCr	25TCr
Minority Interest	3.46TCr	4.41TCr	5.14TCr	5.18TCr	5.57TCr
Total Equity	19TCr	22TCr	26TCr	28TCr	30TCr
Total Liabilities And Equity	31TCr	36TCr	40TCr	44TCr	48TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	20Cr	20Cr	20Cr	20Cr	20Cr
ECS Total Common Shares Outstanding	20Cr	20Cr	20Cr	20Cr	20Cr
Book Value / Share	793.52	912.57	1.03T	1.17T	1.26T
Tangible Book Value	14TCr	17TCr	19TCr	21TCr	20TCr
Tangible Book Value Per Share	713.16	834.88	951.02	1.08T	1.04T
Total Debt	4.38TCr	5.38TCr	4.46TCr	4.78TCr	6.56TCr
Net Debt	-2.36TCr	-2.79TCr	-5.23TCr	-4.73TCr	-1.77TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	838Cr	803.8Cr	787.1Cr	722.5Cr	678.8Cr
Minority Interest, Total (Incl. Fin. Div)	3.46TCr	4.41TCr	5.14TCr	5.18TCr	5.57TCr
Inventories - Raw Materials, Total	608.4Cr	745.8Cr	737.2Cr	755.8Cr	781.1Cr
Inventories - Work In Process, Total	192.4Cr	201.2Cr	171.8Cr	165.9Cr	172.7Cr
Inventories - Finished Goods, Total	4.11TCr	6.32TCr	5.78TCr	6.18TCr	7.28TCr
Full Time Employees	4.75T	4.93T	5.17T	5.49T	5.73T
Accumulated Allowance for Doubtful Accounts (Supple)	52Cr	45Cr	69Cr	82Cr	74Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	2.06TCr	4.1TCr	3.97TCr	2.62TCr	2.58TCr
Depreciation & Amortization - CF	806.8Cr	842.5Cr	911.8Cr	999.9Cr	1.03TCr
Amortization of Goodwill and Intangible Assets - (CF)	86Cr	88Cr	100Cr	117.9Cr	172.7Cr
Depreciation & Amortization, Total	893.3Cr	930Cr	1.01TCr	1.12TCr	1.21TCr
(Gain) Loss From Sale Of Asset	72Cr	50Cr	24Cr	100.1Cr	9.1Cr
(Gain) Loss on Sale of Investments - (CF)	-	-	-67Cr	-397.1Cr	-369.6Cr
Other Operating Activities, Total	-460.9Cr	-956.7Cr	-1.49TCr	-892.1Cr	-680.3Cr
Change In Accounts Receivable	-116.2Cr	-710.9Cr	263.4Cr	199.4Cr	71Cr
Change In Inventories	-69Cr	-2.12TCr	896.9Cr	98Cr	-502.5Cr
Change In Accounts Payable	96Cr	231.1Cr	49Cr	-158.7Cr	-252.3Cr
Change in Other Net Operating Assets	236Cr	121.1Cr	-110.4Cr	226.4Cr	-449.2Cr
Cash from Operations	2.71TCr	1.64TCr	4.55TCr	2.92TCr	1.62TCr
Capital Expenditure	-1.39TCr	-1.48TCr	-1.06TCr	-1.92TCr	-2.01TCr
Sale of Property, Plant, and Equipment	-	132.6Cr	43Cr	-	76Cr
Cash Acquisitions	-	-	-106.8Cr	-544.1Cr	-2.38TCr
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	554.6Cr	-76Cr	111.7Cr	581.2Cr	213.4Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	162.7Cr	379.2Cr	-34Cr	-115.4Cr	-47Cr
Cash from Investing	-673.8Cr	-1.04TCr	-1.05TCr	-2TCr	-4.16TCr
Short Term Debt Issued, Total	500Cr	-	-	-	-
Long-Term Debt Issued, Total	1.01TCr	993.2Cr	-	47Cr	2.51TCr
Total Debt Issued	1.51TCr	993.2Cr	-	47Cr	2.51TCr
Short Term Debt Repaid, Total	-500Cr	-	-44Cr	-26Cr	-4.6Cr
Long-Term Debt Repaid, Total	-506Cr	-	-1.04TCr	-10Cr	-1.08TCr
Total Debt Repaid	-1.01TCr	-	-1.08TCr	-37Cr	-1.08TCr
Repurchase of Common Stock	-	-	-	-299.9Cr	-
Common Dividends Paid	-395.1Cr	-414.7Cr	-730.5Cr	-750.3Cr	-565.9Cr
Common & Preferred Stock Dividends Paid	-395.1Cr	-414.7Cr	-730.5Cr	-750.3Cr	-565.9Cr
Other Financing Activities, Total	-256.3Cr	-165.2Cr	-411.2Cr	-304.5Cr	-204.6Cr
Cash from Financing	-150.6Cr	413.3Cr	-2.22TCr	-1.34TCr	654.8Cr
Foreign Exchange Rate Adjustments	-54Cr	275.8Cr	326.7Cr	266.1Cr	395.4Cr
Miscellaneous Cash Flow Adjustments	-10L	10L	-	10L	10L
Net Change in Cash	1.83TCr	1.29TCr	1.61TCr	-160.1Cr	-1.49TCr
Supplemental Items
Cash Interest Paid	36Cr	33Cr	34Cr	46Cr	74Cr
Cash Income Tax Paid (Refund)	476.7Cr	1.03TCr	1.55TCr	845.9Cr	677.1Cr
Levered Free Cash Flow	1.22TCr	-99Cr	2.79TCr	326.76Cr	-1.22TCr
Unlevered Free Cash Flow	1.24TCr	-79Cr	2.81TCr	354.89Cr	-1.17TCr
Change In Net Working Capital	-390.2Cr	2.24TCr	-488.7Cr	232.1Cr	1.65TCr
Net Debt Issued / Repaid	500.8Cr	993.2Cr	-1.08TCr	9.9Cr	1.43TCr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.57	8.1	6.23	3.32	2.81
Return on Total Capital	5.93	10.55	8.2	4.43	3.71
Return On Equity %	7.65	14.12	11.96	6.63	5.96
Return on Common Equity	6.94	12.31	11.03	7.48	6.84
Margin Analysis
Gross Profit Margin %	41.51	37.73	34.2	33.57	32.99
SG&A Margin	30.07	20.32	20	23.4	24.1
EBITDA Margin %	10.96	17.5	13.71	9.85	9.01
EBITA Margin %	8.07	14.7	11.11	6.9	6.16
EBIT Margin %	7.76	14.41	10.82	6.55	5.68
Income From Continuing Operations Margin %	5.12	9.76	8.18	5.23	4.78
Net Income Margin %	3.8	6.9	6.05	4.77	4.47
Net Avail. For Common Margin %	3.8	6.9	6.05	4.77	4.47
Normalized Net Income Margin	3.63	6.12	4.76	3.83	3.51
Levered Free Cash Flow Margin	4.38	-0.33	7.96	0.96	-3.36
Unlevered Free Cash Flow Margin	4.46	-0.26	8.01	1.05	-3.24
Asset Turnover
Asset Turnover	0.94	0.9	0.92	0.81	0.79
Fixed Assets Turnover	3.85	3.9	4.16	3.5	3.17
Receivables Turnover (Average Receivables)	4.56	4.59	5.05	4.91	5.11
Inventory Turnover (Average Inventory)	3.32	3.08	3.31	3.27	3.17
Short Term Liquidity
Current Ratio	3.25	2.94	3.58	3.04	3.34
Quick Ratio	2.29	1.91	2.46	2.04	2.12
Operating Cash Flow to Current Liabilities	0.48	0.21	0.67	0.36	0.22
Days Sales Outstanding (Average Receivables)	80.06	79.6	72.25	74.59	71.39
Days Outstanding Inventory (Average Inventory)	109.94	118.6	110.38	111.98	115.17
Average Days Payable Outstanding	36.86	32.41	34.68	35.14	33.28
Cash Conversion Cycle (Average Days)	153.14	165.78	147.96	151.43	153.28
Long Term Solvency
Total Debt/Equity	22.84	23.94	17.45	17.04	21.8
Total Debt / Total Capital	18.6	19.31	14.86	14.56	17.9
LT Debt/Equity	20.15	17.04	15.52	11.69	17.71
Long-Term Debt / Total Capital	16.4	13.74	13.22	9.99	14.54
Total Liabilities / Total Assets	37.59	38.04	36.04	35.89	37
EBIT / Interest Expense	62.78	131.38	117.12	49.43	29.43
EBITDA / Interest Expense	88.74	159.56	148.34	74.27	46.67
(EBITDA - Capex) / Interest Expense	48.31	114.83	115.57	31.58	17.9
Total Debt / EBITDA	1.43	1.02	0.93	1.43	2.01
Net Debt / EBITDA	-0.77	-0.53	-1.09	-1.41	-0.54
Total Debt / (EBITDA - Capex)	2.63	1.42	1.19	3.36	5.24
Net Debt / (EBITDA - Capex)	-1.42	-0.74	-1.4	-3.33	-1.41
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-0.98	8.07	16.53	-3.22	6.87
Gross Profit, 1 Yr. Growth %	6.42	-1.78	5.64	-5.01	5.02
EBITDA, 1 Yr. Growth %	25.58	72.48	-8.72	-30.46	-2.24
EBITA, 1 Yr. Growth %	34.63	96.93	-11.95	-39.86	-4.68
EBIT, 1 Yr. Growth %	36.37	100.76	-12.48	-41.38	-7.4
Earnings From Cont. Operations, 1 Yr. Growth %	33.36	106.02	-2.32	-38.08	-2.49
Net Income, 1 Yr. Growth %	17.75	96.42	2.1	-23.72	0.16
Normalized Net Income, 1 Yr. Growth %	19.45	82.31	-9.29	-22.21	-1.95
Diluted EPS Before Extra, 1 Yr. Growth %	18.56	96.42	2.1	-23.47	1.08
Accounts Receivable, 1 Yr. Growth %	1.2	13.63	-1.13	0.41	4.72
Inventory, 1 Yr. Growth %	0.3	47.88	-7.9	6.2	15.88
Net Property, Plant and Equip., 1 Yr. Growth %	7.02	6.7	11.46	17.99	17.86
Total Assets, 1 Yr. Growth %	8.11	18.09	10.14	9.59	9.17
Tangible Book Value, 1 Yr. Growth %	9.25	17.07	13.91	11.86	-3.22
Common Equity, 1 Yr. Growth %	6.17	15	13.04	12.12	7.24
Cash From Operations, 1 Yr. Growth %	130.76	-39.57	177.71	-35.84	-44.63
Capital Expenditures, 1 Yr. Growth %	14.77	6.12	-28.07	80.92	4.86
Levered Free Cash Flow, 1 Yr. Growth %	-1.48T	-108.15	-2.91T	-88.29	-472.77
Unlevered Free Cash Flow, 1 Yr. Growth %	-2.07T	-106.35	-3.67T	-87.37	-430.9
Dividend Per Share, 1 Yr. Growth %	5	76.19	2.7	-23.68	6.9
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.18	3.45	12.22	6.2	1.7
Gross Profit, 2 Yr. CAGR %	3.1	2.24	1.86	0.17	-0.12
EBITDA, 2 Yr. CAGR %	10.15	47.18	25.47	-20.33	-17.55
EBITA, 2 Yr. CAGR %	9.68	62.83	31.68	-27.23	-24.29
EBIT, 2 Yr. CAGR %	10.13	65.46	32.56	-28.37	-26.32
Earnings From Cont. Operations, 2 Yr. CAGR %	7.45	65.75	41.86	-22.23	-22.3
Net Income, 2 Yr. CAGR %	0.78	52.08	41.62	-11.75	-12.59
Normalized Net Income, 2 Yr. CAGR %	2.92	47.57	28.6	-16	-12.67
Diluted EPS Before Extra, 2 Yr. CAGR %	1.27	52.6	41.62	-11.6	-12.05
Accounts Receivable, 2 Yr. CAGR %	1.65	7.23	5.99	-0.36	2.54
Inventory, 2 Yr. CAGR %	3.3	21.79	16.7	-1.1	10.93
Net Property, Plant and Equip., 2 Yr. CAGR %	11.08	6.86	9.06	14.68	17.92
Total Assets, 2 Yr. CAGR %	3.39	12.99	14.04	9.86	9.38
Tangible Book Value, 2 Yr. CAGR %	4.84	13.09	15.48	12.88	4.05
Common Equity, 2 Yr. CAGR %	2.89	10.5	14.02	12.58	9.65
Cash From Operations, 2 Yr. CAGR %	41.64	18.09	29.54	33.48	-40.4
Capital Expenditures, 2 Yr. CAGR %	14.18	10.36	-12.63	14.08	37.73
Levered Free Cash Flow, 2 Yr. CAGR %	68.27	6.22	51.18	81.28	-33.92
Unlevered Free Cash Flow, 2 Yr. CAGR %	65.18	11.89	50.41	112.2	-35.36
Dividend Per Share, 2 Yr. CAGR %	8.01	36.01	34.52	-11.47	-9.68
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.26	2.74	7.64	6.82	6.42
Gross Profit, 3 Yr. CAGR %	3.38	1.45	3.36	-0.48	1.76
EBITDA, 3 Yr. CAGR %	10.08	27.91	25.51	3.06	-14.71
EBITA, 3 Yr. CAGR %	10.92	33.31	32.65	1.41	-20.38
EBIT, 3 Yr. CAGR %	11.42	34.54	33.82	0.99	-21.97
Earnings From Cont. Operations, 3 Yr. CAGR %	4.4	33.49	38.97	7.61	-16.14
Net Income, 3 Yr. CAGR %	-1.39	25.89	33.17	15.22	-7.94
Normalized Net Income, 3 Yr. CAGR %	5.71	24.53	25.47	8.76	-11.56
Diluted EPS Before Extra, 3 Yr. CAGR %	-0.91	26.29	33.47	15.35	-7.56
Accounts Receivable, 3 Yr. CAGR %	2.2	5.49	4.37	4.1	1.3
Inventory, 3 Yr. CAGR %	4.61	16.42	10.96	13.09	4.26
Net Property, Plant and Equip., 3 Yr. CAGR %	9.14	9.6	8.37	11.96	15.73
Total Assets, 3 Yr. CAGR %	2.25	8.08	12.03	12.54	9.63
Tangible Book Value, 3 Yr. CAGR %	4.7	8.77	13.36	14.26	7.24
Common Equity, 3 Yr. CAGR %	2.63	6.78	11.34	13.38	10.77
Cash From Operations, 3 Yr. CAGR %	18.55	6.63	57.03	2.49	-0.45
Capital Expenditures, 3 Yr. CAGR %	28.21	11.42	-4.32	11.36	10.92
Levered Free Cash Flow, 3 Yr. CAGR %	15.5	-38.67	216.33	-35.55	130.52
Unlevered Free Cash Flow, 3 Yr. CAGR %	14.17	-44.27	254.74	-34.14	146.07
Dividend Per Share, 3 Yr. CAGR %	9.49	27.15	23.86	11.36	-5.73
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.32	5.14	5.51	4.11	5.22
Gross Profit, 5 Yr. CAGR %	5.25	3.85	2.77	0.94	1.95
EBITDA, 5 Yr. CAGR %	12.61	22.97	16	5.84	6.09
EBITA, 5 Yr. CAGR %	13.97	26.69	18.8	4.64	6
EBIT, 5 Yr. CAGR %	13.08	26.18	19.43	4.55	5.4
Earnings From Cont. Operations, 5 Yr. CAGR %	12.91	26.04	18.02	7.55	10.13
Net Income, 5 Yr. CAGR %	8.43	19.62	13.97	9.21	12.53
Normalized Net Income, 5 Yr. CAGR %	6.68	17.54	14.33	6.38	8.54
Diluted EPS Before Extra, 5 Yr. CAGR %	8.81	20.04	14.3	9.5	12.96
Accounts Receivable, 5 Yr. CAGR %	2.86	3.88	3.7	3.11	3.64
Inventory, 5 Yr. CAGR %	7.5	12.76	9.29	9.07	10.95
Net Property, Plant and Equip., 5 Yr. CAGR %	7.09	6.15	9.11	11.6	12.1
Total Assets, 5 Yr. CAGR %	3.92	5.73	6.82	8.79	10.96
Tangible Book Value, 5 Yr. CAGR %	3.38	5.75	8.89	10.39	9.54
Common Equity, 5 Yr. CAGR %	3.77	5.97	7.04	9.06	10.66
Cash From Operations, 5 Yr. CAGR %	21.18	5.01	22.83	16.65	6.59
Capital Expenditures, 5 Yr. CAGR %	19.36	22.39	9.97	12.48	10.69
Levered Free Cash Flow, 5 Yr. CAGR %	22.57	-7.37	28.63	-5.39	69.08
Unlevered Free Cash Flow, 5 Yr. CAGR %	21.5	-14.83	27.48	-4.86	79.54
Dividend Per Share, 5 Yr. CAGR %	13.81	23.27	18.89	10.01	9.16